Nothing Special   »   [go: up one dir, main page]

MX2013004406A - Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion. - Google Patents

Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion.

Info

Publication number
MX2013004406A
MX2013004406A MX2013004406A MX2013004406A MX2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A
Authority
MX
Mexico
Prior art keywords
treating diabetes
insulin injections
injection intervals
injections administered
diabetes melitus
Prior art date
Application number
MX2013004406A
Other languages
English (en)
Other versions
MX366314B (es
Inventor
Thue Johansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX2013004406A publication Critical patent/MX2013004406A/es
Publication of MX366314B publication Critical patent/MX366314B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a métodos para el tratamiento de una condición o enfermedad donde la administración de insulina será de beneficio, que comprenden administrar a un paciente en necesidad de lo mismo, dosis eficaces de una insulina, análogo de insulina o derivado de esto, que exhibe un perfil prolongado de acción, en donde las dosis se administran a intervalos de duración variable.
MX2013004406A 2010-10-27 2011-10-27 Uso de derivados de insulina por inyecciones con intervalos variables. MX366314B (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40720610P 2010-10-27 2010-10-27
EP11170366 2010-10-27
EP10189115 2010-10-27
US201161498645P 2011-06-20 2011-06-20
PCT/EP2011/068870 WO2012055967A2 (en) 2010-10-27 2011-10-27 Treating diabetes melitus using insulin injections administered with varying injection intervals

Publications (2)

Publication Number Publication Date
MX2013004406A true MX2013004406A (es) 2013-05-17
MX366314B MX366314B (es) 2019-07-05

Family

ID=43571114

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004406A MX366314B (es) 2010-10-27 2011-10-27 Uso de derivados de insulina por inyecciones con intervalos variables.

Country Status (11)

Country Link
US (1) US20130261051A1 (es)
EP (1) EP2632478B1 (es)
KR (1) KR20130139297A (es)
CN (1) CN103167878A (es)
AU (2) AU2011322495A1 (es)
CA (1) CA2815419A1 (es)
MX (1) MX366314B (es)
PL (1) PL2632478T3 (es)
RS (1) RS59423B1 (es)
SI (1) SI2632478T1 (es)
WO (1) WO2012055967A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1969004B1 (en) 2005-12-28 2011-08-10 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
ES2772731T3 (es) 2008-10-17 2020-07-08 Sanofi Aventis Deutschland Combinación de una insulina y un agonista de GLP-1
CN102202683A (zh) 2008-10-30 2011-09-28 诺沃-诺迪斯克有限公司 用少于每日一次的注射频率注射胰岛素来治疗糖尿病
EP2554183B1 (de) 2009-11-13 2018-04-04 Sanofi-Aventis Deutschland GmbH Pharmazeutische Zusammensetzung umfassend einen GLP-1-Agonisten, ein Insulin und Methionin
PE20121316A1 (es) 2009-11-13 2012-10-05 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1 y metionina
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
RU2546520C2 (ru) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー／エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
RU2670106C2 (ru) 2012-05-01 2018-10-18 Ново Нордиск А/С Фармацевтическая композиция
EP2976096B1 (en) * 2013-03-20 2019-02-27 Novo Nordisk A/S Insulin dosing regimen
SG11201506888VA (en) 2013-04-03 2015-09-29 Sanofi Sa Treatment of diabetes mellitus by long-acting formulations of insulins
JP2016519127A (ja) 2013-04-30 2016-06-30 ノヴォ ノルディスク アー／エス 新規投与レジメン
AU2014333979B2 (en) * 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
ES2949095T3 (es) 2014-12-12 2023-09-25 Sanofi Aventis Deutschland Formulación de relación fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2020225129A1 (en) * 2019-05-03 2020-11-12 Diavein Method for treating diabetes and associated disorders with vascular electrical stimulation therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
AU641631B2 (en) 1988-12-23 1993-09-30 Novo Nordisk A/S Human insulin analogues
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US20040138099A1 (en) * 2002-11-29 2004-07-15 Draeger Eberhard Kurt Insulin administration regimens for the treatment of subjects with diabetes
PT2107069E (pt) * 2003-08-05 2013-04-23 Novo Nordisk As Novos derivados de insulina
PL2107069T3 (pl) 2003-08-05 2013-06-28 Novo Nordisk As Nowe pochodne insuliny
EP1969004B1 (en) 2005-12-28 2011-08-10 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
EP2386572B1 (en) * 2006-05-09 2015-07-08 Novo Nordisk A/S Insulin derivative
CN101677947B (zh) 2007-06-13 2013-07-17 诺沃-诺迪斯克有限公司 包含胰岛素衍生物的药物制剂
CN102202683A (zh) * 2008-10-30 2011-09-28 诺沃-诺迪斯克有限公司 用少于每日一次的注射频率注射胰岛素来治疗糖尿病

Also Published As

Publication number Publication date
MX366314B (es) 2019-07-05
CN103167878A (zh) 2013-06-19
AU2016202917B2 (en) 2017-07-20
US20130261051A1 (en) 2013-10-03
PL2632478T3 (pl) 2020-03-31
CA2815419A1 (en) 2012-05-03
AU2016202917A1 (en) 2016-05-26
AU2011322495A1 (en) 2013-04-11
KR20130139297A (ko) 2013-12-20
EP2632478B1 (en) 2019-07-24
WO2012055967A2 (en) 2012-05-03
EP2632478A2 (en) 2013-09-04
WO2012055967A3 (en) 2012-06-21
SI2632478T1 (sl) 2019-11-29
RS59423B1 (sr) 2019-11-29

Similar Documents

Publication Publication Date Title
MX366314B (es) Uso de derivados de insulina por inyecciones con intervalos variables.
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
EA201400030A1 (ru) Способ непрерывного подкожного введения инсулина с использованием фермента, разрушающего хиалуронан
EA201201657A1 (ru) Лечение диабета
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
MY167234A (en) Novel glucagon analogues
NI201000105A (es) Régimen de dosificación asociado con ésteres de paliperidona inyectables de acción prolongada.
EA201370178A1 (ru) Стабильные составы для парентеральной инъекции пептидных лекарственных средств
BR112013024973A2 (pt) prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2
EA201300522A1 (ru) Фармацевтические комбинации для лечения метаболических нарушений
MX2013011175A (es) Analogos de glucagon novedosos.
MX362503B (es) Combinacion farmaceutica para mejorar el control glucemico como terapia adicional a la insulina basal.
MX2019007779A (es) Metodo cosmetico para el tratamiento o reduccion de paniculopatia edemato-fibroesclerotica (pefe).
CO2018000196A2 (es) Agente terapéutico para tratar el síndrome de hunter y método de tratamiento
AR082312A1 (es) Una composicion farmaceutica de combinacion para tratar diabetes y desordenes metabolicos
MX2013009842A (es) Composicion que comprende receptor gamma activado por proliferador de peroxisoma.
PH12015501931A1 (en) Treatment of diabetes mellitus by long-acting formulations of insulins
MD20150120A2 (ro) Tratamentul bolilor neurodegenerative şi miopatice de agregare proteică prin administrarea parenterală a trehalozei
EA201491702A1 (ru) Оптимизированные терапевтические агенты для подкожного введения
EA201691420A1 (ru) Композиции енолазы 1 (eno1) и их применение
MX2016000220A (es) Regulacion del metabolismo de glucosa usando anticuerpos anti-cgrp.
BR112013010345A2 (pt) tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
EA201391063A1 (ru) Аполипопротеин a-iv в качестве антидиабетического пептида
WO2014018763A3 (en) Method of treating type i diabetes using apolipoprotein aiv
GB2544385A (en) Modulators of caspase-6

Legal Events

Date Code Title Description
GD Licence granted
FG Grant or registration